ANGO - Angiodynamic Inc
IEX Last Trade
7.45
-0.010 -0.134%
Share volume: 252,937
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$7.46
-0.01
-0.13%
View ratios
| Fiscal Date | 2022-08-31 | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 | 2023-11-30 | 2024-02-29 | 2024-05-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2022-10-11 | 2023-01-06 | 2023-03-31 | 2023-08-03 | 2023-10-05 | 2024-01-08 | 2024-04-09 | 2024-07-25 | |
| Assets | |||||||||
| Total Assets | 557.652 M | 558.207 M | 542.849 M | 532.637 M | 493.949 M | 499.623 M | 324.842 M | 317.671 M | |
| Current Assets | 151.371 M | 158.830 M | 152.574 M | 163.542 M | 175.475 M | 185.468 M | 196.907 M | 193.253 M | |
| Inventories | 57.609 M | 63.177 M | 63.532 M | 55.325 M | 59.972 M | 64.254 M | 58.068 M | 60.616 M | |
| Other Current Assets | 15.612 M | 12.944 M | 8.039 M | 4.617 M | 8.162 M | 8.715 M | 10.913 M | 6.570 M | |
| Short Term Investments | 15.612 M | 12.944 M | 8.039 M | 4.617 M | 8.162 M | 8.715 M | 10.913 M | 6.570 M | |
| Total Receivables | 53.586 M | 52.852 M | 50.892 M | 52.826 M | 49.755 M | 51.603 M | 49.475 M | 50.011 M | |
| Current Cash | 24.564 M | 29.857 M | 30.111 M | 44.620 M | 57.586 M | 60.896 M | 78.451 M | 76.056 M | |
| Total Non-current Assets | 406.281 M | 399.377 M | 390.275 M | 369.095 M | 318.474 M | 314.155 M | 127.935 M | 124.418 M | |
| Property Plant Equipment | 46.189 M | 45.957 M | 45.559 M | 44.384 M | 43.356 M | 42.557 M | 37.040 M | 35.666 M | |
| Other Assets | 11.078 M | 10.722 M | 10.729 M | 10.676 M | 9.430 M | 8.481 M | 9.325 M | 11.369 M | |
| Intangible Assets | 147.976 M | 141.943 M | 134.011 M | 111.144 M | 106.671 M | 103.891 M | 81.570 M | 77.383 M | |
| Goodwill | 201.038 M | 200.755 M | 199.976 M | 159.238 M | 159.017 M | 159.226 M | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 557.652 M | 558.207 M | 542.849 M | 532.637 M | 493.949 M | 499.623 M | 324.842 M | 317.671 M | |
| Total liabilities | 143.611 M | 150.249 M | 145.194 M | 154.341 M | 66.145 M | 98.397 M | 106.144 M | 112.085 M | |
| Total current liabilities | 66.390 M | 73.567 M | 69.632 M | 83.825 M | 57.452 M | 78.037 M | 85.874 M | 91.155 M | |
| Accounts Payable | 29.258 M | 34.688 M | 35.600 M | 40.445 M | 24.807 M | 37.650 M | 35.152 M | 37.751 M | |
| Other liabilities | 12.308 M | 12.596 M | 12.265 M | 7.885 M | 7.414 M | 2.602 M | 14.353 M | 16.078 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 49.798 M | 49.796 M | 49.807 M | 49.818 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 12.308 M | 12.596 M | 12.265 M | 7.885 M | 7.414 M | 2.602 M | 14.353 M | 16.078 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 414.041 M | 407.958 M | 397.655 M | 378.296 M | 427.804 M | 401.226 M | 218.698 M | 205.586 M | |
| Common stock | 39.302 M | 39.490 M | 39.509 M | 39.619 M | 39.842 M | 40.219 M | 40.234 M | 40.429 M | |
| Retained earnings | -171.417 M | -179.903 M | -189.388 M | -210.855 M | -164.971 M | -194.019 M | -381.755 M | -395.204 M |